S&P 500
(0.65%) 5 161.28 points
Dow Jones
(0.29%) 38 787 points
Nasdaq
(0.69%) 16 267 points
Oil
(0.12%) $78.20
Gas
(4.20%) $2.23
Gold
(1.06%) $2 333.10
Silver
(3.43%) $27.61
Platinum
(-0.03%) $965.05
USD/EUR
(-0.07%) $0.928
USD/NOK
(-0.43%) $10.83
USD/GBP
(-0.16%) $0.796
USD/RUB
(-0.10%) $91.36

Обновления в реальном времени для Bliss GVS Pharma Limited [BLISSGVS.NS]

Биржа: NSE Сектор: Healthcare Промышленность: Drug Manufacturers—Specialty & Generic
Upcoming Earnings Alert

2 days till quarter result
(bmo 2024-05-08)

Expected move: +/- 4.64%

Последнее обновление6 май 2024 @ 12:59

-5.12% INR 112.95

Live Chart Being Loaded With Signals

Commentary (6 май 2024 @ 12:59):

Bliss GVS Pharma Limited develops, manufactures, and markets pharmaceutical formulations in India. It offers pharma products, including capsules, creams/gels/ointments, dry powder for injections and oral suspensions, effervescent tablets, eye/ear drops, injections, liquid preparations, lotions, lozenges, nasal solutions, oral solids, parenterals, pessaries, sachets, soft gelatin capsules, suppositories, suspensions, syrups, tablets, topical preparations, and transdermal patches...

Stats
Объем за сегодня 576 113
Средний объем 677 784
Рыночная капитализация 11.82B
EPS INR0 ( 2024-01-22 )
Дата следующего отчета о доходах ( INR0 ) 2024-05-08
Last Dividend INR0.500 ( 2023-07-12 )
Next Dividend INR0 ( N/A )
P/E 13.61
ATR14 INR0.129 (0.11%)

Объем Корреляция

Длинно: 0.23 (neutral)
Кратко: -0.14 (neutral)
Signal:(44.029) Neutral

Bliss GVS Pharma Limited Корреляция

10 Самые положительные корреляции
10 Самые отрицательные корреляции

Вы знали?

Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).

Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.

Bliss GVS Pharma Limited Корреляция - Валюта/Сырье

The country flag 0.23
( neutral )
The country flag 0.26
( neutral )
The country flag 0.39
( neutral )
The country flag 0.24
( neutral )
The country flag -0.04
( neutral )
The country flag 0.03
( neutral )

Bliss GVS Pharma Limited Финансовые показатели

Annual 2022
Выручка: INR7.52B
Валовая прибыль: INR3.50B (46.60 %)
EPS: INR6.83
FY 2022
Выручка: INR7.52B
Валовая прибыль: INR3.50B (46.60 %)
EPS: INR6.83
FY 2022
Выручка: INR7.38B
Валовая прибыль: INR3.47B (47.02 %)
EPS: INR2.24
FY 2021
Выручка: INR5.69B
Валовая прибыль: INR2.40B (42.16 %)
EPS: INR6.64

Financial Reports:

No articles found.

Bliss GVS Pharma Limited Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0.500
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)

Bliss GVS Pharma Limited Dividend Information - Dividend Junior

Dividend Sustainability Score: 4.34 - low (44.24%) | Divividend Growth Potential Score: 4.25 - Stable (14.95%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend INR0.300 2010-11-25
Last Dividend INR0.500 2023-07-12
Next Dividend INR0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 19 --
Total Paid Out INR9.35 --
Avg. Dividend % Per Year 0.46% --
Score 2.16 --
Div. Sustainability Score 4.34
Div.Growth Potential Score 4.25
Div. Directional Score 4.30 --
Next Divdend (Est)
(2024-12-10)
INR0.496 Estimate 3.25 %
Dividend Stability
0.26 Very Poor
Dividend Score
2.16
Pay Frequency
Annually
Yearly Payout
Year Amount Yield
2010 INR0 0.00%
2011 INR0 0.00%
2012 INR0 0.00%
2013 INR0 0.00%
2014 INR0 0.00%
2015 INR0 0.00%
2016 INR0 0.00%
2017 INR0 0.00%
2018 INR1.000 0.48%
2019 INR1.000 0.61%
2020 INR0.500 0.34%
2021 INR1.000 0.49%
2022 INR1.000 0.96%
2023 INR0.500 0.69%
2024 INR0 0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
SPAL.NS Dividend Junior 2023-09-15 Sporadic 8 0.44%
MOTHERSON.NS Dividend Junior 2023-08-11 Annually 23 0.63%
HERITGFOOD.NS Dividend Junior 2023-08-14 Annually 23 0.44%
BIKAJI.NS Dividend Junior 2023-06-08 Insufficient data to determine frequency 2 0.06%
RANEHOLDIN.NS Dividend Junior 2023-07-27 Annually 21 0.95%
KOPRAN.NS Dividend Junior 2023-09-07 Annually 5 1.18%
ESCORTS.NS Dividend Junior 2023-06-30 Annually 28 0.21%
ALPHAGEO.NS Dividend Junior 2023-09-22 Annually 18 2.07%
SYMPHONY.NS Dividend Knight 2023-08-04 Semi-Annually 14 0.47%
NESCO.NS Dividend Junior 2023-07-28 Annually 17 0.40%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.1161.5007.6810.00[0 - 0.5]
returnOnAssetsTTM01.20000[0 - 0.3]
returnOnEquityTTM0.1291.5009.6810.00[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM00.800-5.00-4.00[1 - 3]
quickRatioTTM00.800-4.71-3.76[0.8 - 2.5]
cashRatioTTM01.500-1.111-1.667[0.2 - 2]
debtRatioTTM0-1.50000[0 - 0.6]
interestCoverageTTM12.331.0006.546.54[3 - 30]
operatingCashFlowPerShareTTM2.702.009.1010.00[0 - 30]
freeCashFlowPerShareTTM2.702.008.6510.00[0 - 20]
debtEquityRatioTTM0-1.50000[0 - 2.5]
grossProfitMarginTTM0.4771.0005.385.38[0.2 - 0.8]
operatingProfitMarginTTM0.1651.0008.698.69[0.1 - 0.6]
cashFlowToDebtRatioTTM01.000-1.111-1.111[0.2 - 2]
assetTurnoverTTM00.800-3.33-2.67[0.5 - 2]
Total Score4.34

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM13.651.0008.720[1 - 100]
returnOnEquityTTM0.1292.509.7910.00[0.1 - 1.5]
freeCashFlowPerShareTTM2.702.009.1010.00[0 - 30]
dividendYielPercentageTTM0.4361.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM2.702.009.1010.00[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM0.03711.500-3.090[0.5 - 2]
operatingCashFlowSalesRatioTTM0.03731.000-1.5660[0.1 - 0.5]
Total Score4.25

Bliss GVS Pharma Limited

Bliss GVS Pharma Limited develops, manufactures, and markets pharmaceutical formulations in India. It offers pharma products, including capsules, creams/gels/ointments, dry powder for injections and oral suspensions, effervescent tablets, eye/ear drops, injections, liquid preparations, lotions, lozenges, nasal solutions, oral solids, parenterals, pessaries, sachets, soft gelatin capsules, suppositories, suspensions, syrups, tablets, topical preparations, and transdermal patches. The company also provides other healthcare products, such as balms, creams, lotions, lozenges, nasal inhalers, over the counter products, petroleum jellies, powders, roll-ons, shampoos, soaps, solutions, sprays, syrups, and vaginal washes. In addition, it offers therapeutic products consisting of anti-bacterial, anti-dandruff shampoo, amino acid preparation, iron tonic, antitussive, appetite stimulant, anti-allergic, body supplement, anti-biotic, anti-diabetic, anti-diarrheal, anti-emetic, anti-fungal, anti-haemorrhoidal, anti-helmintic, anti-infective, anti-inflammatory, anti-malarial, anti-microbial, anti-migraine, anti-oxidant, anti-protozoal, ear wax solvent, anti-pyretic, anti-septic, anti-spasmodic, anti-ulcer, and anti-ulcerant; and analgesic, oral rehydration, antacid, anxiolytic, appetizer, cough syrup, erectile dysfunction, haematinic, hand sanitizer, health supplement, insecticide, laryngitis, pharyngitis, laxative, lubricant, mosquito repellant, nasal decongestant, nutritional supplement, moisturizer, prickly heat powder, skin lightening lotion, vaginal contraceptive, vaginal hygiene, and vitamin supplements, as well as medicated, complexion, moisturizing, and total protection soaps. The company also exports its products. Bliss GVS Pharma Limited was incorporated in 1984 and is based in Mumbai, India.

О Торговые сигналы

Данные торговые сигналы, представленные на этой странице, помогают определить, когда следует ПОКУПАТЬ или ПРОДАВАТЬ NA. Сигналы имеют задержку более 1 минуты. Пожалуйста, примите во внимание, что существует вероятность ошибки или неточностей в силу различных микро и макро факторов влияющих на фондовые рынки.

Данные тор“о”ые сигна“ы не являются определен“ыми, и getagraph.com не несет ответственности за какие-либо действия, предпринятые в от“ошении этих сигналов, как описано в Terms of Use. Сигналы основаны на широком спектре индикаторов технического анализа